HTH
Signal active
Investment Firm
Overview
HTH is a private Life Science Investment Company. Headquartered in Milan (IT), the company invests worldwide in Biotech, Medtech, Digital Health with a special focus on AI enabled technologies (but not limited to).
Highlights
Founded
2020
Industry
Employees
1-10
Investment
6
Lead Investment
5
Exits
undefined
Stages
Seed, Early Stage Venture
Investor Type
Private Equity Firm, Venture Capital
Location
Milano, Lombardia, Italy, Europe
Contact Information
Social
Profile Resume
HTH, established in 2020 and headquartered in Europe., specializes in Seed, Early Stage Venture investments across Financial Services, Venture Capital, Finance, Biotechnology, Life Science, Health Care, Medical, Apps, Fitness, Wellness. Their recent investments include UCL Technology Fund, Lys Therapeutics, AirGo, MassVentures, Nina Capital. The highest investment round they participated in was $1.4B. Among their most notable exits are UCL Technology Fund and Lys Therapeutics. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Employees
N/A
Investment portfolio
HTH has made 6 investments. Their most recent investment was on Nov 14, 2022, when Lys Therapeutics raised $3.1M.
investments
6
Diversity investments
1
Lead investments
5
Number of exits
undefined
Investments
6
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Aug 29, 2022 | Neurofenix | Service Industry | 6.9M |
| Sep 23, 2022 | - | - | 5.0M |
| Nov 14, 2022 | Lys Therapeutics | Biotechnology | 3.1M |
| Jun 24, 2024 | - | - | 10.0M |
NeurofenixExits
0
Funding Timeline
Funding rounds
6
Investors
0
Funds
0
Funding Rounds
6
HTH has raised 6 rounds. Their latest funding was raised on Jun 24, 2024 from a Seed Round - EpilepsyGTx round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Aug 29, 2022 | Series A - Neurofenix | - | 6.9M | - |
| Sep 23, 2022 | Series A - Leuko | - | 5.0M | - |
| Nov 14, 2022 | Seed Round - Lys Therapeutics | - | 3.1M | - |
| Jun 24, 2024 | Seed Round - EpilepsyGTx | - | 10.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
Funding Round
Jun 24, 2024
EpilepsyGTx raised $10000000 on 2024-06-24 in Seed Round
Funding Round
Nov 14, 2022
Lys Therapeutics raised $3095950 on 2022-11-14 in Seed Round
Funding Round
Sep 23, 2022
Leuko raised $5000000 on 2022-09-23 in Series A
Funding Round
Aug 29, 2022
Neurofenix raised $6915832 on 2022-08-29 in Series A
Funding Round
Jun 07, 2021
Endostart raised $9996526 on 2021-06-07 in Series B